Safely Transition Patients on Chronic Immune Thrombocytopenia Meds at Home
The new med fostamatinib (Tavalisse, TAV-ah-lees) will lead to questions about CHRONIC treatment of immune thrombocytopenia (ITP).
We're familiar with treating most patients with acute ITP using high-dose steroids...IVIG...or both.
If thrombocytopenia persists, splenectomy is typically the next step. But newer data support trying chronic ITP meds first.